ABSTRACT Administration of human chorionic gonadotropin (hCG) to male rats was followed by dose-related changes in luteinizing hormone (LH) receptors in the testis. After treatment with a low dose of hCG (10 international units), the number of LHI receptors increased slightly over the first 24 hi, then fell to about 30o of the control value. These changes occurred with occupancy of only 8% of the available receptors, and were initially accompanied by increased basal testosterone production in vitro with no change in basal 3':5'-cyclic AMP production. (3, 4) . Recently, we have observed a sustained loss of testicular LH receptors in rats after systemic administration of ovine LH or hCG (6). The ability of gonadotropins to induce loss of their own receptors is analogous to the regulation of receptors for insulin, somatotropin (growth hormone), thyrotropin releasing hormone, and catecholamines by the respective hormones (7-13). Loss of receptors in adrenergic systems has been shown to be accompanied by refractoriness or desensitization of adenylate cyclase,.indicating that changes in hormone receptors influence the regulation of target cell responses (12, 13) . In this report, we describe the functional relations between negative regulation of LH/hCG receptors and desensitization of cyclic AMP and steroidogenic responses in the testes of rats treated with exogenous gonadotropin.
By contrast, a 20-fold higher dose of hCG caused more rapid ad complete loss of LH receptors, with major and transient occu- pancy of receptors at 24 hr and marked elevations of basal cyclic AMP and testosterone production in vitro. The initial occupancy of receptors was accompanied by a rapid fall in the cyclic AMP response to hCG in vitro, and was followed by marked receptor loss and inhibition of the cyclic AMP response for upto 5 days. The testosterone response to hCG in vitro was completely inhibited for about 3 days, then rose to the control leve at 5 ays, when only a small p oion of the original receptor sites and cyclic AMP response hadbegun to return. Such complete recovery of the steroidogenic response when only a fraction of the receptor population had returned was consistent with the presence of receptor reserve or "spare" receptors in the testis.
These studies have demonstrated that negative regulation of LH receptors by exogenous gonadotropin is accompanied by consequent.changes in cyclic AMP and testosterone responses to hCG in vitro. Hormone-induced desensitization of interstitial cell responses was initially related to occupancy of LH receptors and later to a protracted loss of receptor sites.
The mechanism of action of gonadotropins upon testicular interstitial cells has been studied extensively in vitro (1) (2) (3) (4) (5) . Occupancy of plasma-membrane receptors for luteinizing hormone (LH)* by LH or by human chorionic gonadotropin (hCG) is followed by stimulation of 3':5'-cyclic AMP production and testosterone synthesis. Also, a marked dissociation between the cyclic AMP and testosterone responses to hCG has been observed at low gonadotropin concentrations (2) (3) (4) . Measurements of receptor occupancy during hormonal stimulation of interstitial cells have revealed the presence of "spare" or "reserve" receptors, in excess of the number required for maximum testosterone production (3) . By (3, 4) . Recently, we have observed a sustained loss of testicular LH receptors in rats after systemic administration of ovine LH or hCG (6) . The ability of gonadotropins to induce loss of their own receptors is analogous to the regulation of receptors for insulin, somatotropin (growth hormone), thyrotropin releasing hormone, and catecholamines by the respective hormones (7) (8) (9) (10) (11) (12) (13) . Loss of receptors in adrenergic systems has been shown to be accompanied by refractoriness or desensitization of adenylate cyclase,.indicating that changes in hormone receptors influence the regulation of target cell responses (12, 13) . In in total receptor content, followed by a progressive loss of receptors. Injection of 10 IU of hCG caused occupancy of only a small proportion (about 8%) of the total receptor population. The total receptor content remained near the control level for 1 day, and then dropped to one-third of the control level for several days. In contrast, injection of 200 IU of hCG resulted in a more rapid and obvious increase of total receptor content after occupancy of a fraction of the available receptors, which then began to drop at 12 hr as receptor occupancy rose toward its maximum of almost total saturation (i.e., 100% occupancy) at 24 hr. At that time, the disappearance of available LH/hCG binding sites was completely attributable to occupancy by the administered hCG. Thereafter, the total receptor content remained low for 3 days, and began to recover 5 days after injection. At the third and fourth days after hCG injection, occupancy by hCG was less than 10% of the 24-hr value, yet receptor sites were almost undetectable by binding assay.
Effects of hCG treatment on cyclic AMP and steroidogenic responses of isolated testis
Testes removed at serial intervals after hCG injection were incubated with 500 ng of hCG per ml to evaluate the responsiveness of cyclic AMP and testosterone production to hormone stimulation in vitro. Basal cyclic AMP production did not change after 10 IU of hCG, but was significantly increased after injection of 200 IU of hCG (Fig. 3, solid lines) . Each dose of hCG caused marked inhibition of gonadotropin-induced cyclic AMP production in vitro (Fig. 3, dashed lines) . After 10 IU of hCG, the cyclic AMP response to hCG in vitro was decreased at 3 hr, reached a minimum after 1 day, and gradually recovered thereafter. Administration of 200 IU of hCG was followed by a more marked and prolonged reduction of the cyclic AMP response to hCG, which decreased within 1 hr after hormone treatment and remained inhibited for several days. The return of a minor cyclic AMP response to hCG was detected 5 days after injection, and the full hormone response was again present at 8 days.
The steroidogenic capacity of the testis in vitro also showed significant changes after hCG administration. Both 10 and 200 IU of hCG caused a marked increase in basal levels of testosterone production in vitro (Fig. 4, solid lines) . The injection of 10 IU of hCG induced a low but sustained production of testosterone, whereas the effect of 200 The effects of hCG treatment on cyclic AMP and testosterone responses in vitro were measured by incubating decapsulated testes with and without a saturating concentration of hCG (500 ng/ml). Triplicate vials containing one testis in 2 ml of medium 199 with 0.1% bovine serum albumin and 0.1 mM 1-methyl 3-isobutylxanthine were incubated for 3 hr at 340 with constant shaking. After incubation, 1 ml of medium was removed for testosterone determination by direct radioimmunoassay (2). The remaining medium was added to tubes containing an equal volume of phosphate-buffered saline-0. 1% bovine serum albumin with 2 mM theophylline, placed in a boiling-water bath for 5 min to destroy phosphodiesterase activity, and analyzed for cyclic AMP content by radioimmunoassay (15) .
RESULTS
Serum and testicular concentrations of hCG Subcutaneous injection of 10 or 200 IU of hCG was followed by dose-related increases in serum hCG, which peaked after 6-12 hr at 5 and 100 ng/ml, respectively, and fell with a halflife of about 24 hr (Fig. 1) . Measurement of tissue-bound hCG showed a rise in testicular hCG content that peaked 24 hr after injection at both dose levels, and fell to low values over the next 1-2 days (Fig. 2, open bars) . Testicular content of LH/hCG receptors Injection of both doses of hCG caused an initial slight increase in binding of 12-I-labeled hCG, followed by inhibition of binding for several days (Fig. 2, solid lines) . After 10 IU of hCG, the number of testicular LH receptors remained near the control level for 24 hr, then fell by two-thirds at 2 days and remained low for several days. After 200 IU of hCG, the number of available LH receptors remained near the control level for 12 hr, then dropped rapidly to very low levels by 24 hr. Binding of 125I-labeled hCG remained low or undetectable for several days, and began to recover 5 days after injection.
Measurement of tissue-bound hCG (i.e., occupied receptor sites) allowed the calculation of total receptor content, by addition of the occupied and free receptor sites (Fig. 2, dashed  lines) . The results demonstrated that the hormone-induced change in testis receptors was characterized by an initial rise that cyclic AMP and testosterone responses are markedly dissociated during hormonal stimulation of Leydig cells in vitro (3, 4) .
Retention of the maximum testosterone response to hCG in vitro, during major loss of the cyclic AMP response, is also consistent with this dissociation. The more prolonged changes after hCG administration indicate that the gradual return of receptor sites is accompanied by recovery of cyclic AMP responses in vitro, presumably reflecting the return of hormone-responsive adenylate cyclase activity. During this time, the testosterone response to hCG in vitro was normal, indicating the presence of excess receptors which are "spare" in relation to steroidogenesis (3, 4) . Thus, loss of about two-thirds of the receptors did not impair the ability of the interstitial cells to produce a maximum testosterone response when exposed to a saturating concentration of gonadotropin.
After the larger dose of hCG (200 IU), loss of hCG binding capacity occurred more rapidly and was initially due to occupancy of receptors by the administered hormone. However, receptor occupancy had declined to low values by the third day, and the reduced binding capacity of testes from hCG-treated rats at this time was caused by extensive loss of receptor sites. This loss of receptors persisted until the fifth day, and was followed by a return to about two-thirds of the normal value on the seventh day. As noted with the low dose of hCG, cyclic AMP responses to gonadotropin in vitro dropped rapidly after treatment with 200 IU of hCG. However, the higher dose of hCG also caused a transient rise in basal cyclic AMP production in vitro, which was completed within 12 hr and followed by prolonged loss of hormone responsiveness for up to 6 days. The corresponding changes in testosterone production in vitro were initially similar to those observed in cyclic AMP production. However, the steroid response returned to the control level between 3 (7) (8) (9) (10) ; also, thyrotropin releasing hormone and catecholamines induce receptor loss after ligand-hormone interaction (11) (12) (13) . Tissue-bound hormone was not measured in these reports, in which estimations of receptor loss were based upon the assumption of negligible occupancy during in vitro assay of binding sites. In the present study, measurement of tissue-bound hormone by radioimmunoassay provided direct evidence of the decrease in total, as well as available, LH/hCG receptors after hCG treatment in vivo.
Desensitization of cyclic AMP production and steroidogenesis in target cells after hormonal treatment in vivo offers a unique opportunity to study the relationships between hormone receptors and hormone-induced responses. Comparison of the time courses of receptor loss and desensitization of the cyclic AMP response revealed that two separate processes were involved. The occupancy of a small fraction of receptor sites by hCG in vivo rapidly caused inhibition of the cyclic AMP response, probably via desensitization at the level of adenylate cyclase. Receptor loss took place at a later time, after initial occupancy and presumably through processes involving receptor degradation and/or inhibition of synthesis of new receptors. Desensitization of adenylate cyclase activity has also been demonstrated in adrenergic systems and could be correlated with loss of ligand binding capacity (12, 13) . In addition, hCG-induced receptor loss and desensitization of adenylate cyclase activity has been observed in the luteinized rat ovary (16) .
Relatively low levels of circulating LH are present in male rats (17) , and interstitial cells are probably rarely exposed to the high concentrations of hormone used in the present study.
However, it is likely that desensitization by' circulating gonadotropin is important in certain pathological and physiological states. For example, men with choriocarcinoma sometimes exhibit extremely high levels of plasma hCG without a corresponding increase in testosterone secretion (16) . Our findings support the view (9) that this lack of testicular response to high gonadotropin levels could be due to negative regulation of the interstitial cell receptors for LH and hCG. In the ovary, desensitization of adenylate cyclase has been observed in Graafian follicles and corpus luteum after endogenous elevations of gonadotropin secretion during the estrus cycle and pregnancy in rats and rabbits (19) (20) (21) , as well as after injection of hCG (22) . Finally, the inhibition of ovarian function (23) , ovulation (24) , and endocrine-dependent mammary tumors (25) 
